Takeda Pharmaceutical Co (SSE:4502) Deferred Tax : 円-91,406 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Takeda Pharmaceutical Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Takeda Pharmaceutical Co's change in deferred tax for the three months ended in Mar. 2024 was 円-44,528 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was 円-91,406 Mil.

Takeda Pharmaceutical Co Deferred Tax Historical Data

The historical data trend for Takeda Pharmaceutical Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Deferred Tax Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Deferred Tax

Get a 7-Day Free Trial

-105,044.00

-9,936.00

72,405.00

58,052.00

-91,406.00

Takeda Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Deferred Tax	Get a 7-Day Free Trial															16,779.00	45,627.00	-48,009.00	-44,496.00	-44,528.00

Takeda Pharmaceutical Co Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-91,406 Mil.

Takeda Pharmaceutical Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (SSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (SSE:4502) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (SSE:4502) Headlines

No Headlines